In a recent, interesting study, Bodamer et al. 1 reported that the structural R52C and the promoter Ϫ550GϾC variants of the MBL-2 gene are significantly associated with newborn prematurity. In particular, R52C polymorphism prevalence was increased and Ϫ550GϾC was decreased in premature infants, supporting the possible infectious etiology of preterm delivery. Furthermore, O/O genotype was also associated with prematurity. These MBL-2 variants may be linked to reduced amounts of MBL protein, depending on their combinations. In fact, another study 2 appeared in the same period and reported that premature infants had lower serum MBL values.
In this letter, we report data concerning the study of MBL-2 variants determined by a commercially available reverse dot blot kit, (Innoplia MBL2 Assay, plus Autolipa and LIRAS software, Innogenetics, Ghent, Belgium). Eighty-nine preterm infants were subdivided by either week of gestational age (Յ27 weeks or Ͼ27 weeks) or birth weight (1000 g as a cut-off, i.e., extremely low birth weight), representing two methods to evaluate the grade of prematurity. The results (see Table 1 ) showed that premature infants with gestational age Յ27 weeks were significantly more likely to be carrying the R52C variant compared with those Ͼ27 weeks (P ϭ 0.01). This was also true for infants with the "O" genotype (P ϭ 0.031). The Ϫ550GϾC genotype was significantly lower in infants with gestational age Յ27 weeks (P ϭ 0.02). Similar results were observed when the birth weight was Յ1000 grams versus Ͼ1000 grams (data not shown). The MBL-2 Ϫ221GϾC variant results were similar to those of Ϫ550GϾC as these two variants are in strong linkage disequilibrium. Infants with the R52C variant were also characterized by higher median duration of continuous positive airway pressure (CPAP) The promoter -550GϾC variant was often homozygous (40%) and often associated with Ϫ221 GϾC variant (therefore serum MBL levels are expected to be very low), whereas R52C variant was exclusively heterozygous (14%) and rarely O/O (therefore the serum MBL levels are expected to be normal or slightly reduced). These data are in agreement with the work of Frakking et al., 2 which reported that premature infants had MBL levels lower than those of infants born at term.
Recent studies revealing a high prevalence of variants in different populations and evolutionary observations 3 support the idea that MBL-2 variants may sometimes have protective effects or the opposite in different situations. It is protective when an aggressive pathogen capable of activating MBL should be eliminated by an inflammatory complement-dependent response, whereas a dangerous effect may happen when this persistent activation leads to uncontrolled inflammatory processes.
In conclusion, our data confirm and extend the importance of knowing the MBL-2 polymorphisms, so as to be aware of the Situs inversus totalis, renal and pancreatic dysplasia, and cysts as an autosomal recessive new entity?
To the Editor:
The letter "Atrioventricular canal defect in Bardet-Biedl syndrome: Clinical evidence supporting the link between atrioventricular canal defect and polydactyly syndromes with ciliary dysfunction" 1 presents a summary of "syndromes associating atrioventricular canal defect (AVCD) and postaxial polydactyly" in Table 1 .
The authors stated, "dextrocardia in the setting of situs inversus has been described in Meckel syndrome and Meckellike syndrome." To support this statement, the authors cited our article. 2 However, we would like to point out that in this study 2 and in our previous related study, 3 the features described did not include polydactyly. This syndrome is therefore not a "Meckel-like syndrome."
The syndrome we described 2,3 is autosomal recessive and is characterized by situs inversus totalis, polycystic kidney and pancreas, oligohydramnios, and bowing of the lower extremities. Furthermore, the syndrome is distinct from Ivemark syndrome because there were no hepatic cysts.
